Target  ||| S:0 E:7 ||| NN
analysis  ||| S:7 E:16 ||| NN
and  ||| S:16 E:20 ||| CC
retrospective  ||| S:20 E:34 ||| JJ
screening  ||| S:34 E:44 ||| NN
of  ||| S:44 E:47 ||| IN
veterinary  ||| S:47 E:58 ||| JJ
drugs ||| S:58 E:63 ||| NNS
,  ||| S:63 E:65 ||| ,
ergot  ||| S:65 E:71 ||| JJ
alkaloids ||| S:71 E:80 ||| NN
,  ||| S:80 E:82 ||| ,
plant  ||| S:82 E:88 ||| NN
toxins  ||| S:88 E:95 ||| NNS
and  ||| S:95 E:99 ||| CC
other  ||| S:99 E:105 ||| JJ
undesirable  ||| S:105 E:117 ||| JJ
substances  ||| S:117 E:128 ||| NNS
in  ||| S:128 E:131 ||| IN
feed  ||| S:131 E:136 ||| NN
using  ||| S:136 E:142 ||| VBG
liquid  ||| S:142 E:149 ||| JJ
chromatography-high  ||| S:149 E:169 ||| JJ
resolution  ||| S:169 E:180 ||| NN
mass  ||| S:180 E:185 ||| NN
spectrometry  ||| S:185 E:198 ||| VBD
A  ||| S:198 E:200 ||| DT
comprehensive  ||| S:200 E:214 ||| JJ
strategy  ||| S:214 E:223 ||| NN
combining  ||| S:223 E:233 ||| VBG
a  ||| S:233 E:235 ||| DT
quantitative  ||| S:235 E:248 ||| JJ
method  ||| S:248 E:255 ||| NN
for  ||| S:255 E:259 ||| IN
77  ||| S:259 E:262 ||| CD
banned  ||| S:262 E:269 ||| VBN
veterinary  ||| S:269 E:280 ||| JJ
drugs ||| S:280 E:285 ||| NNS
,  ||| S:285 E:287 ||| ,
mycotoxins ||| S:287 E:297 ||| NN
,  ||| S:297 E:299 ||| ,
ergot  ||| S:299 E:305 ||| JJ
alkaloids  ||| S:305 E:315 ||| NN
and  ||| S:315 E:319 ||| CC
plant  ||| S:319 E:325 ||| NN
toxins ||| S:325 E:331 ||| NN
,  ||| S:331 E:333 ||| ,
and  ||| S:333 E:337 ||| CC
a  ||| S:337 E:339 ||| DT
post-target  ||| S:339 E:351 ||| JJ
screening  ||| S:351 E:361 ||| NN
for  ||| S:361 E:365 ||| IN
425  ||| S:365 E:369 ||| CD
substances  ||| S:369 E:380 ||| NNS
including  ||| S:380 E:390 ||| VBG
pesticides  ||| S:390 E:401 ||| NNS
and  ||| S:401 E:405 ||| CC
environmental  ||| S:405 E:419 ||| JJ
contaminants  ||| S:419 E:432 ||| NN
in  ||| S:432 E:435 ||| IN
feed  ||| S:435 E:440 ||| NN
were  ||| S:440 E:445 ||| VBD
developed  ||| S:445 E:455 ||| VBN
using  ||| S:455 E:461 ||| VBG
a  ||| S:461 E:463 ||| DT
QuEChERS-based  ||| S:463 E:478 ||| JJ
extraction  ||| S:478 E:489 ||| NN
and  ||| S:489 E:493 ||| CC
an  ||| S:493 E:496 ||| DT
ultra-high  ||| S:496 E:507 ||| JJ
performance  ||| S:507 E:519 ||| NN
liquid  ||| S:519 E:526 ||| NN
chromatography  ||| S:526 E:541 ||| VBZ
coupled  ||| S:541 E:549 ||| VBN
to  ||| S:549 E:552 ||| TO
high-resolution  ||| S:552 E:568 ||| JJ
mass  ||| S:568 E:573 ||| NN
spectrometry  ||| S:573 E:586 ||| NNS
( ||| S:586 E:587 ||| -LRB-
UHPLC-HRMS ||| S:587 E:597 ||| NNP
) ||| S:597 E:598 ||| -RRB-
.  ||| S:598 E:600 ||| .
The  ||| S:600 E:604 ||| DT
quantitative  ||| S:604 E:617 ||| JJ
method  ||| S:617 E:624 ||| NN
was  ||| S:624 E:628 ||| VBD
validated  ||| S:628 E:638 ||| VBN
after  ||| S:638 E:644 ||| IN
previous  ||| S:644 E:653 ||| JJ
statistical  ||| S:653 E:665 ||| JJ
optimisation  ||| S:665 E:678 ||| NN
of  ||| S:678 E:681 ||| IN
the  ||| S:681 E:685 ||| DT
main  ||| S:685 E:690 ||| JJ
parameters  ||| S:690 E:701 ||| NNS
governing  ||| S:701 E:711 ||| VBG
ionisation ||| S:711 E:721 ||| NN
,  ||| S:721 E:723 ||| ,
and  ||| S:723 E:727 ||| CC
presented  ||| S:727 E:737 ||| VBN
recoveries  ||| S:737 E:748 ||| NNS
ranging ||| S:748 E:755 ||| VBG
,  ||| S:755 E:757 ||| ,
in  ||| S:757 E:760 ||| IN
general ||| S:760 E:767 ||| JJ
,  ||| S:767 E:769 ||| ,
from  ||| S:769 E:774 ||| IN
80  ||| S:774 E:777 ||| CD
to  ||| S:777 E:780 ||| TO
120 ||| S:780 E:783 ||| CD
% ||| S:783 E:784 ||| NN
,  ||| S:784 E:786 ||| ,
with  ||| S:786 E:791 ||| IN
a  ||| S:791 E:793 ||| DT
precision  ||| S:793 E:803 ||| NN
in  ||| S:803 E:806 ||| IN
terms  ||| S:806 E:812 ||| NNS
of  ||| S:812 E:815 ||| IN
Relative  ||| S:815 E:824 ||| NNP
Standard  ||| S:824 E:833 ||| NNP
Deviation  ||| S:833 E:843 ||| NNP
( ||| S:843 E:844 ||| -LRB-
RSD ||| S:844 E:847 ||| NNP
)  ||| S:847 E:849 ||| -RRB-
lower  ||| S:849 E:855 ||| JJR
than  ||| S:855 E:860 ||| IN
20 ||| S:860 E:862 ||| CD
% ||| S:862 E:863 ||| NN
.  ||| S:863 E:865 ||| .
The  ||| S:865 E:869 ||| DT
full-scan  ||| S:869 E:879 ||| JJ
accurate  ||| S:879 E:888 ||| JJ
mass  ||| S:888 E:893 ||| NN
data  ||| S:893 E:898 ||| NNS
were  ||| S:898 E:903 ||| VBD
acquired  ||| S:903 E:912 ||| VBN
with  ||| S:912 E:917 ||| IN
a  ||| S:917 E:919 ||| DT
resolving  ||| S:919 E:929 ||| JJ
power  ||| S:929 E:935 ||| NN
of  ||| S:935 E:938 ||| IN
50000  ||| S:938 E:944 ||| CD
FWHM  ||| S:944 E:949 ||| NNP
and  ||| S:949 E:953 ||| CC
a  ||| S:953 E:955 ||| DT
mass  ||| S:955 E:960 ||| JJ
accuracy  ||| S:960 E:969 ||| NN
lower  ||| S:969 E:975 ||| JJR
than  ||| S:975 E:980 ||| IN
5ppm ||| S:980 E:984 ||| CD
.  ||| S:984 E:986 ||| .
The  ||| S:986 E:990 ||| DT
method  ||| S:990 E:997 ||| NN
LOQ  ||| S:997 E:1001 ||| NNP
was  ||| S:1001 E:1005 ||| VBD
lower  ||| S:1005 E:1011 ||| JJR
than  ||| S:1011 E:1016 ||| IN
12.5µgkg ||| S:1016 E:1024 ||| NNP
( ||| S:1024 E:1025 ||| -LRB-
-1 ||| S:1025 E:1027 ||| NNP
)  ||| S:1027 E:1029 ||| -RRB-
for  ||| S:1029 E:1033 ||| IN
the  ||| S:1033 E:1037 ||| DT
majority  ||| S:1037 E:1046 ||| NN
of  ||| S:1046 E:1049 ||| IN
the  ||| S:1049 E:1053 ||| DT
veterinary  ||| S:1053 E:1064 ||| JJ
drugs  ||| S:1064 E:1070 ||| NNS
and  ||| S:1070 E:1074 ||| CC
plant  ||| S:1074 E:1080 ||| NN
toxins  ||| S:1080 E:1087 ||| NNS
and  ||| S:1087 E:1091 ||| CC
20µgkg ||| S:1091 E:1097 ||| NNP
( ||| S:1097 E:1098 ||| -LRB-
-1 ||| S:1098 E:1100 ||| NNP
)  ||| S:1100 E:1102 ||| -RRB-
for  ||| S:1102 E:1106 ||| IN
ergot  ||| S:1106 E:1112 ||| JJ
alkaloids ||| S:1112 E:1121 ||| NN
.  ||| S:1121 E:1123 ||| .
For  ||| S:1123 E:1127 ||| IN
post-target  ||| S:1127 E:1139 ||| JJ
screening  ||| S:1139 E:1149 ||| VBG
a  ||| S:1149 E:1151 ||| DT
customised  ||| S:1151 E:1162 ||| JJ
theoretical  ||| S:1162 E:1174 ||| JJ
database  ||| S:1174 E:1183 ||| NN
including  ||| S:1183 E:1193 ||| VBG
the  ||| S:1193 E:1197 ||| DT
exact  ||| S:1197 E:1203 ||| JJ
mass ||| S:1203 E:1207 ||| NN
,  ||| S:1207 E:1209 ||| ,
the  ||| S:1209 E:1213 ||| DT
polarity  ||| S:1213 E:1222 ||| NN
of  ||| S:1222 E:1225 ||| IN
acquisition  ||| S:1225 E:1237 ||| NN
and  ||| S:1237 E:1241 ||| CC
the  ||| S:1241 E:1245 ||| DT
expected  ||| S:1245 E:1254 ||| JJ
adducts  ||| S:1254 E:1262 ||| NN
was  ||| S:1262 E:1266 ||| VBD
built  ||| S:1266 E:1272 ||| VBN
and  ||| S:1272 E:1276 ||| CC
used  ||| S:1276 E:1281 ||| VBN
for  ||| S:1281 E:1285 ||| IN
post-run  ||| S:1285 E:1294 ||| JJ
retrospective  ||| S:1294 E:1308 ||| JJ
screening ||| S:1308 E:1317 ||| NN
.  ||| S:1317 E:1319 ||| .
The  ||| S:1319 E:1323 ||| DT
analytical  ||| S:1323 E:1334 ||| JJ
strategy  ||| S:1334 E:1343 ||| NN
was  ||| S:1343 E:1347 ||| VBD
applied  ||| S:1347 E:1355 ||| VBN
to  ||| S:1355 E:1358 ||| TO
32  ||| S:1358 E:1361 ||| CD
feed  ||| S:1361 E:1366 ||| NN
samples  ||| S:1366 E:1374 ||| NNS
collected  ||| S:1374 E:1384 ||| VBN
from  ||| S:1384 E:1389 ||| IN
farms  ||| S:1389 E:1395 ||| NNS
of  ||| S:1395 E:1398 ||| IN
the  ||| S:1398 E:1402 ||| DT
Valencia  ||| S:1402 E:1411 ||| NNP
Region  ||| S:1411 E:1418 ||| NNP
( ||| S:1418 E:1419 ||| -LRB-
Spain ||| S:1419 E:1424 ||| NNP
) ||| S:1424 E:1425 ||| -RRB-
.  ||| S:1425 E:1427 ||| .
Florfenicol ||| S:1427 E:1438 ||| NNP
,  ||| S:1438 E:1440 ||| ,
zearalenone  ||| S:1440 E:1452 ||| NN
and  ||| S:1452 E:1456 ||| CC
atropine  ||| S:1456 E:1465 ||| NNS
were  ||| S:1465 E:1470 ||| VBD
identified  ||| S:1470 E:1481 ||| VBN
and  ||| S:1481 E:1485 ||| CC
quantified  ||| S:1485 E:1496 ||| VBN
at  ||| S:1496 E:1499 ||| IN
concentrations  ||| S:1499 E:1514 ||| NNS
around  ||| S:1514 E:1521 ||| IN
10µgkg ||| S:1521 E:1527 ||| NNP
( ||| S:1527 E:1528 ||| -LRB-
-1 ||| S:1528 E:1530 ||| NNP
) ||| S:1530 E:1531 ||| -RRB-
.  ||| S:1531 E:1533 ||| .
In  ||| S:1533 E:1536 ||| IN
the  ||| S:1536 E:1540 ||| DT
post-target  ||| S:1540 E:1552 ||| JJ
screening  ||| S:1552 E:1562 ||| NN
of  ||| S:1562 E:1565 ||| IN
the  ||| S:1565 E:1569 ||| DT
real  ||| S:1569 E:1574 ||| JJ
samples ||| S:1574 E:1581 ||| NNS
,  ||| S:1581 E:1583 ||| ,
Sulfadiazine ||| S:1583 E:1595 ||| NNP
,  ||| S:1595 E:1597 ||| ,
Thrimetoprin  ||| S:1597 E:1610 ||| NNP
and  ||| S:1610 E:1614 ||| CC
Pirimiphosmethyl  ||| S:1614 E:1631 ||| NNP
were  ||| S:1631 E:1636 ||| VBD
tentatively  ||| S:1636 E:1648 ||| RB
identified ||| S:1648 E:1658 ||| VBN
.  ||| S:1658 E:1660 ||| .
